A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer
Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This is a study to test the safety and efficacy of an investigational chemotherapy agent in
patients with advanced prostate cancer. Subjects who meet all entry criteria and have signed
the informed consent will be enrolled in the study. Participants will be required to attend
regular clinic visits to receive study medication and have their status monitored. A detailed
explanation can be provided by the investigator conducting the study.